Investors & Media Investor FAQs Investor Relations Overview Corporate Governance Press Releases & Statements Events & Presentations SEC Filings Annuals and Proxies Investor FAQs Financials & Filings Stock Information Analyst Coverage Email Alerts Subscription Notice of Pendency of Settlement of Action Investor FAQs Show All Show all Where is Sage Therapeutics' corporate headquarters? Sage Therapeutics is headquartered at 55 Cambridge Parkway, Cambridge, MA 02142. The main phone number is 617-299-8380. When was Sage Therapeutics founded? Sage was incorporated in 2010 in the state of Delaware. How is Sage Therapeutics' stock traded? Sage Therapeutics is traded on the NASDAQ Global Market under the ticker symbol SAGE and its CUSIP number is 78667J 108. When did Sage Therapeutics go public? Sage Therapeutics’ initial public offering (IPO) occurred on July 18, 2014. When is Sage Therapeutics' fiscal year-end? December 31st. Who is Sage Therapeutics' transfer agent? Computershare P.O. Box 505000 Louisville, KY 40233 http://www-us.computershare.com/contactus/ Does Sage Therapeutics have a direct stock purchase plan? Sage Therapeutics does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice. Who are Sage Therapeutics' independent auditors? PricewaterhouseCoopers LLP 101 Seaport Boulevard, Suite 500 Boston, MA 02110 (617) 530-5000 Where can I view Sage Therapeutics' corporate news releases? The Sage Therapeutics press release archives can be accessed at https://investor.sagerx.com/press-releases Where can I view documents that Sage Therapeutics has filed with the Securities & Exchange Commission (SEC)? The Sage Therapeutics SEC filings can be accessed at https://investor.sagerx.com/sec-filings or www.sec.gov. Whom should I contact if I have further questions? Investor questions and inquiries can be submitted to the Sage Therapeutics investor relations department by contacting ir@sagerx.com or 617-299-8380.
Investor FAQs Show All Show all Where is Sage Therapeutics' corporate headquarters? Sage Therapeutics is headquartered at 55 Cambridge Parkway, Cambridge, MA 02142. The main phone number is 617-299-8380. When was Sage Therapeutics founded? Sage was incorporated in 2010 in the state of Delaware. How is Sage Therapeutics' stock traded? Sage Therapeutics is traded on the NASDAQ Global Market under the ticker symbol SAGE and its CUSIP number is 78667J 108. When did Sage Therapeutics go public? Sage Therapeutics’ initial public offering (IPO) occurred on July 18, 2014. When is Sage Therapeutics' fiscal year-end? December 31st. Who is Sage Therapeutics' transfer agent? Computershare P.O. Box 505000 Louisville, KY 40233 http://www-us.computershare.com/contactus/ Does Sage Therapeutics have a direct stock purchase plan? Sage Therapeutics does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice. Who are Sage Therapeutics' independent auditors? PricewaterhouseCoopers LLP 101 Seaport Boulevard, Suite 500 Boston, MA 02110 (617) 530-5000 Where can I view Sage Therapeutics' corporate news releases? The Sage Therapeutics press release archives can be accessed at https://investor.sagerx.com/press-releases Where can I view documents that Sage Therapeutics has filed with the Securities & Exchange Commission (SEC)? The Sage Therapeutics SEC filings can be accessed at https://investor.sagerx.com/sec-filings or www.sec.gov. Whom should I contact if I have further questions? Investor questions and inquiries can be submitted to the Sage Therapeutics investor relations department by contacting ir@sagerx.com or 617-299-8380.
